Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...

WASHINGTON, Jan 18, 2025 (BSS/AFP) - US health officials announced Friday they were awarding $590 million to Moderna to ...

The flu vaccine is generally about 40% effective at completely preventing influenza, according to Blumberg. The flu vaccine ...

Influenza vaccine offered comparable effectiveness in children across all severity levels of illness, a 5-year-long CDC study ...

With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...

The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as ...

Influenza vaccine is effective for preventing severe influenza illness among children, according to a study published.